Vets Find the First Cat Case of Human-Like Marfan Syndrome

Gary and Shaggy grew fast, too fast: long limbed, big pawed, taller in the leg than any alley cat has business being, and nobody thought much of it until their eyes started to go wrong. A splice site error in the cats’ FBN1 gene turned out to be leaky rather than fully broken, letting about a quarter of their fibrillin protein assemble correctly and keeping two ordinary house cat littermates alive for years despite carrying that error in double, a dose that should have been lethal on its own. Their disease was Marfan syndrome, the same connective tissue disorder that stretches the limbs and threatens the aortas of roughly one in three thousand to five thousand people, and Gary and Shaggy are the first cats anyone has confirmed have it at the molecular level. Veterinarians at Cornell University and Ghent University pieced the case together only after one brother’s aorta gave way.

Marfan syndrome has been documented almost exclusively in humans, where a single altered copy of FBN1 is usually enough to cause it. Spontaneous, disease-causing FBN1 variants have otherwise been cataloged in only one other species, cattle, according to the Online Mendelian Inheritance in Animals database that veterinary geneticists use to track such findings, and engineered mice, pigs and rabbits carrying broken copies of the gene exist in labs without fully reproducing the human disease.

Fibrillin-1, the protein FBN1 builds, is a scaffolding molecule that assembles into microfibrils running through ligaments, skin, blood vessel walls and the fibers that hold the eye’s lens in place. Those microfibrils do more than hold tissue together: they also trap and control a family of growth signals called TGF-beta (transforming growth factor beta), so a fibrillin fault can throw off tissue growth as much as tissue strength. In humans, a single faulty copy of FBN1 is normally enough to loosen that scaffolding throughout the body, producing the tall stature, long fingers, dislocated lenses and swollen aortas of Marfan syndrome. Gary and Shaggy, unusually, had two damaged copies rather than one, a state researchers thought should be far more destructive, not merely survivable into adulthood.

That expectation set up the central puzzle of the case: complete loss of working FBN1 kills mice before birth, so a homozygous mutation in a cat should have done something similarly severe, not just dislocate a pair of lenses. Instead, one of the two lived to seven, the other to five, both eventually dying of the disease’s cardiovascular complications rather than never being born at all.

A Body Built Too Long

Postmortem measurements told the skeletal side of the story: one cat’s leg bones, the radius, tibia and metacarpals, ran 42.5 percent longer through the lower leg and 46.0 percent longer through the paw than an average male house cat’s. The aorta told the vascular side. At death, one animal’s main vessel had swollen to roughly three times the width expected for a cat that size, thin walled and starting to tear. A necropsy on the second cat found the tear had already happened: a one centimeter rupture in the vessel wall, and about 40 milliliters of blood pooled around a heart it should have kept feeding.

It took a veterinarian familiar with human genetics to first recognize the pattern connecting long limbs, loose lenses and a failing aorta, and the case eventually reached Jacquelyn Evans, a geneticist at Cornell’s Baker Institute for Animal Health who helped lead the molecular workup. “The findings provide a foundation for improved veterinary diagnostics,” Evans said. “It can help veterinarians recognize similar cases in the future and may help develop genetic tests.”

The Gene With a Leak In It

Whole genome sequencing of one cat turned up 743 candidate variants inside the FBN1 region, spread across the gene’s 65 exons, and narrowed the list to a single change absent from seven unrelated cats and later from more than 1,000 other cat genomes screened through the University of Missouri’s 99 Lives Cat Genome Sequencing Initiative, a public database built to catch exactly this kind of rare feline variant. The change sat three letters upstream of an exon boundary, in a stretch of DNA that tells the cell’s splicing machinery where to cut, and only one of four computer programs built to predict such damage saw it coming. RNA sequencing settled the question the software could not: in blood drawn from one of the cats, roughly 73 percent of the gene’s messenger RNA had skipped the affected exon entirely, producing a shortened, likely dysfunctional fibrillin-1. The remaining copies, about a quarter of the total, spliced normally, and that leftover trickle of correct protein, described in the structural biology of fibrillin-1 as essential scaffolding, is the leak the whole mechanism depends on: enough fibrillin-1 to build a body, just not enough to build one properly. Reviewers applying formal variant classification guidelines combined four separate lines of evidence, one of them rated very strong, to call the mutation disease-causing rather than incidental.

None of this proves the mutation is dangerous in a single dose, since every other cat tested was homozygous for the healthy version and the two patients were homozygous for the faulty one. Without parents or surviving littermates available for testing, the researchers cannot say what carrying just one copy would do to a cat, the way a single faulty copy reliably causes Marfan syndrome in people.

The team leaned on a diagnostic framework built for human patients, the revised Ghent nosology, because veterinary medicine has no equivalent checklist of its own, and they say a wider set of feline cases will be needed to know how well the human criteria really transfer. They also examined only the RNA the faulty gene produced, not the protein itself, leaving direct confirmation of a shortened fibrillin-1 molecule as unfinished business.

The bigger pattern here is a familiar one in genetics: a single broken instruction rarely does just one thing, and a leak in that instruction can matter as much as the break itself, the same lesson researchers drew from a Neanderthal-inherited growth hormone variant that adds muscle mass in some people without much else changing, or from a rare, damaged metabolic gene that trims body fat instead of causing the harm a broken gene usually implies. For veterinary medicine, a confirmed molecular diagnosis means a genetic test could eventually catch the mutation in kittens before their lenses ever slip or their aorta starts to stretch, rather than after. “This discovery is a great example of how pet parents can collaborate with veterinary and genetic experts to learn something that could help other animals in the future,” Evans said. “It also showcases the comparative approach that has long been central to research at the Baker Institute for Animal Health.” For human medicine, the reverse direction may matter more: a naturally leaky version of a mutation that is usually all-or-nothing in mouse models gives researchers a rare, real-world look at how much fibrillin-1 a body actually needs to get by.

Cornell’s team has banked the cats’ genetic material and is watching for the next case, feline or otherwise, that might carry the same leak. Whatever shows up next will arrive already knowing what to look for: a gene that did not quite break, and two ordinary house cats who lived long enough to prove it mattered.

FAQ